Skip to content
Tech News
clear
Topics: Today This Week This Month This Year
1.
FDA intends to take action against non-FDA-approved GLP-1 drugs (news.ycombinator.com)
2.
After the FDA crackdown, here’s how some companies are still selling GLP-1s (feeds.feedburner.com)
3.
Novo Nordisk Abruptly Ends Partnership with Hims, Claiming ‘Sham Compounding’ GLP-1 Drugs (gizmodo.com)
4.
Shares of Hims & Hers tumble 26% after FDA says semaglutide is no longer in shortage (cnbc.com)
5.
Shares of Hims & Hers tumble 23% after FDA says semaglutide is no longer in shortage (cnbc.com)
Today's top topics: apple cnet gael cooper pudding pops twin cities windows 11 zdnet woody allen
View all today's topics →